Long-term follow-up of strictureplasty for Crohn's disease.

BACKGROUND: Strictureplasty is an effective means of alleviating obstructive Crohn's disease while conserving bowel length. The aim of this study was to establish long-term outcomes of strictureplasty. METHODS: Between 1978 and 2003, 479 strictureplasties were performed in 100 patients during...

Full description

Bibliographic Details
Main Authors: Fearnhead, N, Chowdhury, R, Box, B, George, B, Jewell, D, Mortensen, N
Format: Journal article
Language:English
Published: 2006
_version_ 1826259089467899904
author Fearnhead, N
Chowdhury, R
Box, B
George, B
Jewell, D
Mortensen, N
author_facet Fearnhead, N
Chowdhury, R
Box, B
George, B
Jewell, D
Mortensen, N
author_sort Fearnhead, N
collection OXFORD
description BACKGROUND: Strictureplasty is an effective means of alleviating obstructive Crohn's disease while conserving bowel length. The aim of this study was to establish long-term outcomes of strictureplasty. METHODS: Between 1978 and 2003, 479 strictureplasties were performed in 100 patients during 159 operations. Information on Crohn's disease, medical therapy, laboratory indices, surgical details, complication rates and outcomes was recorded. The primary endpoint was abdominal reoperation. RESULTS: Mean follow-up was 85.1 (range 0.2-240.9) months. The overall morbidity rate was 22.6 per cent, with septic complications in 11.3 per cent, obstruction in 4.4 per cent and gastrointestinal haemorrhage in 3.8 per cent. The 30-day mortality rate was 0.6 per cent and the procedure-related series mortality rate 3.0 per cent. Perioperative parenteral nutrition was the only marker for morbidity (P < 0.001). Reoperation rates were 52 per cent at a mean of 40.2 (range 0.2-205.8) months after a first, 56 per cent at 26.1 (range 3.5-63.5) months after a second, 86 per cent at 27.4 (range 1.4-74.5) months after a third, and 62.5 per cent at 25.9 (range 7.3-70.5) months following a fourth strictureplasty procedure. The major risk factor for reoperation was young age (P < 0.001). CONCLUSION: Long-term follow-up has confirmed the safety of strictureplasty in Crohn's disease. Morbidity is appreciable, although the surgical mortality rate is low. Reoperation rates are comparable following first and repeat strictureplasty procedures.
first_indexed 2024-03-06T18:44:21Z
format Journal article
id oxford-uuid:0dffccf3-15bf-475b-aceb-f0673e7ba40a
institution University of Oxford
language English
last_indexed 2024-03-06T18:44:21Z
publishDate 2006
record_format dspace
spelling oxford-uuid:0dffccf3-15bf-475b-aceb-f0673e7ba40a2022-03-26T09:43:28ZLong-term follow-up of strictureplasty for Crohn's disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0dffccf3-15bf-475b-aceb-f0673e7ba40aEnglishSymplectic Elements at Oxford2006Fearnhead, NChowdhury, RBox, BGeorge, BJewell, DMortensen, N BACKGROUND: Strictureplasty is an effective means of alleviating obstructive Crohn's disease while conserving bowel length. The aim of this study was to establish long-term outcomes of strictureplasty. METHODS: Between 1978 and 2003, 479 strictureplasties were performed in 100 patients during 159 operations. Information on Crohn's disease, medical therapy, laboratory indices, surgical details, complication rates and outcomes was recorded. The primary endpoint was abdominal reoperation. RESULTS: Mean follow-up was 85.1 (range 0.2-240.9) months. The overall morbidity rate was 22.6 per cent, with septic complications in 11.3 per cent, obstruction in 4.4 per cent and gastrointestinal haemorrhage in 3.8 per cent. The 30-day mortality rate was 0.6 per cent and the procedure-related series mortality rate 3.0 per cent. Perioperative parenteral nutrition was the only marker for morbidity (P < 0.001). Reoperation rates were 52 per cent at a mean of 40.2 (range 0.2-205.8) months after a first, 56 per cent at 26.1 (range 3.5-63.5) months after a second, 86 per cent at 27.4 (range 1.4-74.5) months after a third, and 62.5 per cent at 25.9 (range 7.3-70.5) months following a fourth strictureplasty procedure. The major risk factor for reoperation was young age (P < 0.001). CONCLUSION: Long-term follow-up has confirmed the safety of strictureplasty in Crohn's disease. Morbidity is appreciable, although the surgical mortality rate is low. Reoperation rates are comparable following first and repeat strictureplasty procedures.
spellingShingle Fearnhead, N
Chowdhury, R
Box, B
George, B
Jewell, D
Mortensen, N
Long-term follow-up of strictureplasty for Crohn's disease.
title Long-term follow-up of strictureplasty for Crohn's disease.
title_full Long-term follow-up of strictureplasty for Crohn's disease.
title_fullStr Long-term follow-up of strictureplasty for Crohn's disease.
title_full_unstemmed Long-term follow-up of strictureplasty for Crohn's disease.
title_short Long-term follow-up of strictureplasty for Crohn's disease.
title_sort long term follow up of strictureplasty for crohn s disease
work_keys_str_mv AT fearnheadn longtermfollowupofstrictureplastyforcrohnsdisease
AT chowdhuryr longtermfollowupofstrictureplastyforcrohnsdisease
AT boxb longtermfollowupofstrictureplastyforcrohnsdisease
AT georgeb longtermfollowupofstrictureplastyforcrohnsdisease
AT jewelld longtermfollowupofstrictureplastyforcrohnsdisease
AT mortensenn longtermfollowupofstrictureplastyforcrohnsdisease